Roche Diagnostics India Pvt. Ltd. established in the year 2002 has offices located in Chennai, Delhi, Kolkata and Mumbai with over 400 employees. Our broad range of innovative diagnostic tests and systems play a pivotal role in the groundbreaking area of integrated healthcare solutions and cover early detection, targeted screening, evaluation and monitoring of disease. Roche Diagnostics India works with the objective of “Doing now what patients need next”, thus preparing for the nation’s future healthcare needs.
Roche Diagnostics India announces the launch of its point-of-care NT-proBNP test for screening diabetes patients who are at risk of cardiovascular diseases (CVD) such as heart failure (HF). This breakthrough innovation is designed to bring testing closer to clinics and revolutionise patient care. T... (more)
India is witnessing an increasing prevalence of cardiovascular diseases (CVD) among the younger population. In fact, CVDs are striking Indians at an earlier age than the Western population reveals a survey commissioned by Roche Diagnostics India in partnership with Medisage, a global healthcare kno... (more)
Cervical Cancer is India’s second most common cancer, affecting more than 1.23 lakh women each year. Around 77,000 Indian women die of the disease. Despite being the only preventable cancers, awareness about effective and reliable screening tools remains poor.
The latest integrated system installation will optimize lab resources while providing high-quality results and valued clinical information to clinicians
Empowers the lab to do more in less time within the existing floor plan by integrating clinical chemistry and immunoassay testing onto... (more)
The Elecsys SARS-CoV-2 Antigen test is an automated laboratory assay intended as an aid in the diagnosis of active SARS-CoV-2 infection
Antigen tests can complement PCR tests and help governments and healthcare systems to increase the testing capacities they need to manage SARS-CoV-2(more)
Roche Diagnostics India launched its Quantitative antibody test- Elecsys Anti SARS CoV-2 S in January this year. The test since then has now been widely used in government and private hospitals and labs in various parts across the country. Roche Elecsys Anti SARS CoV-2 S test measures antibodies th... (more)